Ticker > Company >

Dr Agarwals Eye Hsp share price

Dr Agarwals Eye Hospital Ltd.

BSE: 526783 SECTOR: Hospital & Healthcare Services  27.69 K   68   6

5492.25
+95.25 (1.76%)
BSE: Today, 01:16 PM

Price Summary

Today's High

₹ 5587

Today's Low

₹ 5265.35

52 Week High

₹ 7300

52 Week Low

₹ 3500

FinStar

Ownership Below Par
Stock price may face volatility due to ownership structure.
ValuationExpensive
The stock is at a premium valuation at this point.
EfficiencyExcellent
The company knows very well the utilization of its assets.
FinancialsVery Stable
The company possesses stable growth history and manageable debt.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

2581.36 Cr.

Enterprise Value

2665.55 Cr.

No. of Shares

0.47 Cr.

P/E

44.66

P/B

11.38

Face Value

₹ 10

Div. Yield

0.11 %

Book Value (TTM)

₹  482.7

CASH

12.17 Cr.

DEBT

96.36 Cr.

Promoter Holding

71.9 %

EPS (TTM)

₹  122.98

Sales Growth

24.38%

ROE

29.8 %

ROCE

33.26%

Profit Growth

17.88 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year24.38%
3 Year25.44%
5 Year17.68%

Profit Growth

1 Year17.88%
3 Year31.38%
5 Year31.91%

ROE%

1 Year29.8%
3 Year34.21%
5 Year27.27%

ROCE %

1 Year33.26%
3 Year38.28%
5 Year34.83%

Debt/Equity

0.4597

Price to Cash Flow

27.32

Interest Cover Ratio

5.7642

CFO/PAT (5 Yr. Avg.)

2.14471883301347

Shareholding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Jun 2025 71.90 55.45
Mar 2025 71.90 55.45
Dec 2024 71.90 55.45
Sep 2024 71.90 55.45
Jun 2024 71.90 0.00
Investors List
* Figures given above are % of equity capital

 Strengths

  • The company has shown a good profit growth of 31.3785228459116% for the Past 3 years.
  • The company has shown a good revenue growth of 25.4394143139927% for the Past 3 years.
  • Company has been maintaining healthy ROE of 34.2122333333333% over the past 3 years.
  • Company has been maintaining healthy ROCE of 38.2766666666667% over the past 3 years.
  • The Company has been maintaining an effective average operating margins of 27.51602% in the last 5 years.
  • The company has an efficient Cash Conversion Cycle of -246.9007 days.
  • The company has a good cash flow management; CFO/PAT stands at 2.14471883301347.

 Limitations

  • Promoter pledging is high as 55.45%.

Quarterly Result (All Figures in Cr.)

PARTICULARS Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025
Net Sales 100.02 102.19 95.11 99.83 116.92
Total Expenditure 68.61 72.31 69.49 68.24 79.79
Operating Profit 31.41 29.88 25.62 31.59 37.13
Other Income 0.4 2.28 2.31 0.1 0.8
Interest 3.03 3.67 3.85 2.89 4.16
Depreciation 9.87 9.36 10.02 10.2 10.58
Exceptional Items 0 0 0 0 0
Profit Before Tax 18.91 19.13 14.06 18.6 23.19
Tax 4.8 4.98 3.66 2.61 5.93
Profit After Tax 14.11 14.15 10.4 15.99 17.26
Adjusted EPS (Rs) 30.02 30.11 22.13 34.02 36.72

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Net Sales 139.81 201.21 268.1 319.3 397.15
Total Expenditure 109.96 142.56 192.31 227.32 277.97
Operating Profit 29.84 58.65 75.79 91.98 119.18
Other Income 1.95 1.26 1.83 5.18 5.81
Interest 6.96 7.21 8.04 8.3 14.84
Depreciation 19.1 20.39 20.18 26.61 39.45
Exceptional Items 0 0 0 0 0
Profit Before Tax 5.73 32.31 49.4 62.25 70.7
Tax 7.17 8.21 12.48 15.89 16.05
Net Profit -1.44 24.1 36.92 46.36 54.65
Adjusted EPS (Rs.) -3.06 51.28 78.55 98.64 116.28

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity and Liabilities
Share Capital 4.7 4.7 4.7 4.7 4.7
Total Reserves 49.96 73.47 108.64 152.45 204.91
Borrowings 9.96 20.71 35.77 44.46 81.77
Other N/C liabilities 32.47 152.04 176.04 203.35 298.57
Current liabilities 70.35 82.22 96.4 136.11 86.98
Total Liabilities 167.44 333.14 421.55 541.07 676.93
Assets
Net Block 95.72 214.21 260.37 315.63 393.19
Capital WIP 0 26.47 62.21 97.44 127.98
Intangible WIP 0 0 0 0 0
Investments 0 0 0 0 0
Loans & Advances 27.65 42.46 52.43 12.83 99.82
Other N/C Assets 0 0 0 0 0
Current Assets 44.07 50 46.54 115.17 55.94
Total Assets 167.44 333.14 421.55 541.07 676.93
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Profit from operations 5.73 32.31 49.4 62.25 70.7
Adjustment 27.29 27.18 26.8 31.15 50
Changes in Assets & Liabilities 4.17 6.12 4.94 9.98 -6.09
Tax Paid -3.33 -8.93 -11.52 -13.61 -20.13
Operating Cash Flow 33.87 56.68 69.62 89.77 94.48
Investing Cash Flow -10.97 -46.28 -70.61 -70.04 -132.78
Financing Cash Flow -7.6 -3.81 0.26 -14.23 16.58
Net Cash Flow 15.31 6.59 -0.73 5.5 -21.72

Corporate Actions

Investors Details

PARTICULARS Jun 2024% Sep 2024% Dec 2024% Mar 2025% Jun 2025%
promoters 71.90 71.90 71.90 71.90 71.90
PARTICULARS Jun 2024% Sep 2024% Dec 2024% Mar 2025% Jun 2025%
investors 28.10 28.10 28.10 28.10 28.10
investor education and pr... - - - 2.89 2.89
llp 0.33 0.38 0.37 0.35 0.24
malabar india fund limite... - - - 1.33 1.36
malabar midcap fund - - - 1.70 1.70
varun ashok hiremath 1.58 1.62 1.62 1.68 1.88
investor education and pr... 2.86 2.86 2.94 - -

Annual Reports

Title Link
Title Link
Annual Report 2024
Annual Report 2022
Annual Report 2020
Annual Report 2019
Annual Report 2018
Annual Report 2017
Annual Report 2017

Ratings & Research Reports

TYPE AGENCY Link
TYPE AGENCY Link
Credit CRISIL
Credit CRISIL
Credit CRISIL
Credit CRISIL
Credit CRISIL
Credit CRISIL
Credit CRISIL
Credit CRISIL
Credit CRISIL
Credit CRISIL
Credit CRISIL
TYPE AGENCY Link
TYPE AGENCY Link
 No Research reports exist for this company.Report us

Concalls & Presentations

TYPE QUARTER Link
TYPE QUARTER Link
Concall Q3FY25
Concall Q1FY26
TYPE QUARTER Link
TYPE QUARTER Link
Presentation Q4FY25

Company News

Dr Agarwals Eye Hsp - Quaterly Results 12 Aug, 1:11 PM Dr Agarwals Eye Hsp - Quaterly Results 12 Aug, 1:11 PM Dr Agarwals Eye Hsp - Quaterly Results 12 Aug, 1:11 PM Dr Agarwals Eye Hsp - Quaterly Results 28 May, 2:29 PM Dr Agarwals Eye Hsp - Quaterly Results 28 May, 2:29 PM Dr Agarwals Eye Hospital commences operation of new branch in Tamil Nadu 19 Mar, 3:59 PM Dr Agarwals Eye Hsp - Quaterly Results 14 Feb, 4:45 PM Dr Agarwals Eye Hsp - Quaterly Results 14 Feb, 4:45 PM Dr Agarwals Eye Hsp - Quaterly Results 29 Oct, 7:14 PM Dr Agarwals Eye Hsp - Quaterly Results 29 Oct, 7:14 PM Dr. Agarwal’s Eye Hospital informs about closure of trading window 30 Sep, 9:42 AM Dr.Agarwals Eye Hospital informs about disclosures 28 Sep, 11:43 AM Dr. Agarwal’s Eye Hospital informs about disclosure 23 Sep, 10:06 AM Dr. Agarwal’s Eye Hospital informs about commencement of operation 23 Sep, 9:53 AM Dr Agarwals Eye Hsp - Quaterly Results 25 Jul, 12:12 PM Dr Agarwals Eye Hsp - Quaterly Results 25 Jul, 12:12 PM Dr Agarwals Eye Hsp - Quaterly Results 25 Jul, 12:12 PM Dr Agarwals Eye Hospital informs about disclosure 22 Jul, 10:54 AM Dr. Agarwal's Eye Hospital informs about board meeting 18 Jul, 2:36 PM Dr Agarwals Eye Hsp - Quaterly Results 25 Apr, 2:08 PM Dr Agarwals Eye Hsp - Quaterly Results 25 Apr, 2:08 PM Dr Agarwals Eye Hsp - Quaterly Results 25 Apr, 2:08 PM Dr. Agarwal’s Eye Hospital opens new branch in Tamil Nadu 22 Apr, 12:30 PM Dr Agarwals Eye Hsp - Quaterly Results 18 Jan, 4:18 PM Dr Agarwals Eye Hsp - Quaterly Results 18 Jan, 4:18 PM Dr Agarwals Eye Hsp - Quaterly Results 18 Jan, 4:18 PM Dr.Agarwals Eye Hospital informs about loss of share certificate 16 Dec, 11:28 AM Dr Agarwals Eye Hsp - Quaterly Results 20 Oct, 12:18 PM Dr Agarwals Eye Hsp - Quaterly Results 20 Oct, 12:18 PM Dr Agarwals Eye Hsp - Quaterly Results 20 Oct, 12:18 PM Dr Agarwals Eye Hsp - Quaterly Results 4 Aug, 12:12 PM Dr Agarwals Eye Hsp - Quaterly Results 4 Aug, 12:12 PM Dr Agarwals Eye Hsp - Quaterly Results 4 Aug, 12:12 PM Dr.Agarwals Eye Hospital informs about loss of share certificate 19 Jun, 4:16 PM Dr Agarwals Eye Hsp - Quaterly Results 6 May, 7:59 PM Dr Agarwals Eye Hsp - Quaterly Results 6 May, 7:59 PM Dr. Agarwal's Eye Hospital informs about loss of share certificate 30 Jan, 12:19 PM Dr Agarwals Eye Hsp - Quaterly Results 21 Jan, 12:51 PM Dr Agarwals Eye Hsp - Quaterly Results 21 Jan, 12:51 PM Dr Agarwals Eye Hsp - Quaterly Results 21 Jan, 12:51 PM Dr. Agarwal's Eye Hospital informs about loss of share certificate 6 Jan, 4:29 PM Dr Agarwals Eye Hsp - Quaterly Results 7 Nov, 12:41 PM Dr Agarwals Eye Hsp - Quaterly Results 7 Nov, 12:41 PM Dr Agarwals Eye Hsp - Quaterly Results 7 Nov, 12:41 PM Dr.Agarwals Eye Hospital informs about loss of share certificates 13 Oct, 4:51 PM Dr.Agarwals Eye Hospital informs about loss of share certificates 22 Sep, 2:34 PM Dr Agarwals Eye Hsp - Quaterly Results 4 Aug, 2:04 PM Dr Agarwals Eye Hsp - Quaterly Results 4 Aug, 2:04 PM Dr Agarwals Eye Hsp - Quaterly Results 4 Aug, 2:04 PM Dr. Agarwal's Eye Hospital informs about issuance of duplicate share certificate 2 Jul, 11:43 AM

Dr Agarwals Eye Hsp Stock Price Analysis and Quick Research Report. Is Dr Agarwals Eye Hsp an attractive stock to invest in?

Stock investing requires careful analysis of financial data to determine a company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement, which can be time-consuming and cumbersome.

Examining a company's financial ratios is an easier way to determine its performance, which can help to make sense of the overwhelming amount of information in its financial statements. 

Here are a few indispensable ratios that should be a part of every investor’s research process, or, in simpler words, how to analyse Dr Agarwals Eye Hsp. 

  • PE ratio: Price to Earnings ratio, which indicates how much an investor is willing to pay for a share for every rupee of earnings. A general rule of thumb is that shares trading at a low P/E are undervalued (it depends on other factors too). Dr Agarwals Eye Hsp has a PE ratio of 43.8856484903483 which is high and comparatively overvalued.

  • Return on Assets (ROA): Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. Dr Agarwals Eye Hsp has ROA of 8.9737% which is a bad sign for future performance. (Higher values are always desirable.)

  • Current ratio: The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. Dr Agarwals Eye Hsp has a Current ratio of 0.6431.

  • Return on equity: ROE measures the ability of a firm to generate profits from its shareholders' investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. Dr Agarwals Eye Hsp has a ROE of 29.8015%. (Higher is better)

  • Debt to equity ratio: It is a good metric to check out the capital structure along with its performance. Dr Agarwals Eye Hsp has a Debt to Equity ratio of 0.4597 which means that the company has low proportion of debt in its capital.

  • Sales growth: Dr Agarwals Eye Hsp has reported revenue growth of 24.3815% which is fair in relation to its growth and performance. 

  • Operating Margin: This will tell you about the operational efficiency of the company. The operating margin of Dr Agarwals Eye Hsp for the current financial year is 30.0088127911368%.

  • Dividend Yield: It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for Dr Agarwals Eye Hsp is Rs 6 and the yield is 0.1077%.

  • Earnings Per Share: It tells us how much profit is allocated to to each outstanding share of a common stock. The latest EPS of Dr Agarwals Eye Hsp is Rs 122.9787. The higher the EPS, the better it is for investors. 

One can find all the Financial Ratios of Dr Agarwals Eye Hsp in Ticker for free. Also, one can get the intrinsic value of Dr Agarwals Eye Hsp by using Valuation Calculators, which are available with a Finology ONE subscription. 

Dr Agarwals Eye Hsp FAQs

Q1. What is Dr Agarwals Eye Hsp share price today?
Ans: The current share price of Dr Agarwals Eye Hsp is Rs 5397.

Q2. What is the market capitalisation of Dr Agarwals Eye Hsp?
Ans: Dr Agarwals Eye Hsp has a market capitalisation of Rs 2536.59 Cr., calculated based on its latest share price.

Q3. What are the P/E and P/B ratios of Dr Agarwals Eye Hsp?
Ans: The PE ratio of Dr Agarwals Eye Hsp is 43.8856484903483 and the P/B ratio of Dr Agarwals Eye Hsp is 11.180809033149, showing how the stock is valued against its earnings and book value.

Q4. What is the 52-week high and low of Dr Agarwals Eye Hsp share?
Ans: The 52-week high share price of Dr Agarwals Eye Hsp is Rs 7300, and the 52-week low share price of Dr Agarwals Eye Hsp is Rs 3500.

Q5. Does Dr Agarwals Eye Hsp pay dividends?
Ans: Currently, Dr Agarwals Eye Hsp pays dividends. Dividend yield of Dr Agarwals Eye Hsp is around 0.1077%.

Q6. What are the face value and book value of Dr Agarwals Eye Hsp shares?
Ans: The face value of Dr Agarwals Eye Hsp shares is Rs 10, while the book value per share of Dr Agarwals Eye Hsp is around Rs 482.7021. Face value is the nominal value set by the company, whereas book value reflects its accounting worth.

Q7. What is the debt of Dr Agarwals Eye Hsp?
Ans: Dr Agarwals Eye Hsp has a total debt of Rs 96.36 Cr., which affects investor sentiment and financial stability. 

Q8. What are the ROE and ROCE of Dr Agarwals Eye Hsp?
Ans: The ROE of Dr Agarwals Eye Hsp is 29.8015% and ROCE of Dr Agarwals Eye Hsp is 33.2569%. ROE shows how efficiently the company is generating profit from shareholders’ equity, while the ROCE is reflects how efficiently the company uses its capital to generate returns.

Q9. Is Dr Agarwals Eye Hsp a good buy for the long term?
Ans: The Dr Agarwals Eye Hsp long-term outlook depends on debt levels, earnings growth, and sector trends. If it sustains profits and manages debt well, it may be considered for long-term investment.

Q10. Is Dr Agarwals Eye Hsp undervalued or overvalued?
Ans: Based on valuation ratios like P/E, P/B, and EV/EBITDA, one can analyse whether the Dr Agarwals Eye Hsp appears undervalued or overvalued at current levels. You can check detailed valuation metrics and peer comparisons on Finology Ticker.

Q11. How to check Dr Agarwals Eye Hsp’s financials?
Ans: You can review Dr Agarwals Eye Hsp’s financial statements - including balance sheet, income statement, and quarterly results - on Finology Ticker.

Last Updated on:
Brief about Dr Agarwals Eye Hsp
X